NEW YORK (GenomeWeb) – BC Platforms is joining with with medical evidence provider Medaffcon in an effort to harmonize genomic and clinical data gathered from multiple sources, the companies said today. Financial terms of the partnership were not disclosed.

Medaffcon specializes in generating medical evidence from biobank-based research. Under the partnership with Switzerland-based BC Platforms, Medaffcon will be leveraging the global biobank analytics platform, the companies said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.